Antonio Laurenza

5.0k total citations
93 papers, 3.3k citations indexed

About

Antonio Laurenza is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Antonio Laurenza has authored 93 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Psychiatry and Mental health, 52 papers in Pediatrics, Perinatology and Child Health and 29 papers in Cellular and Molecular Neuroscience. Recurrent topics in Antonio Laurenza's work include Epilepsy research and treatment (57 papers), Pharmacological Effects and Toxicity Studies (50 papers) and Neuroscience and Neuropharmacology Research (27 papers). Antonio Laurenza is often cited by papers focused on Epilepsy research and treatment (57 papers), Pharmacological Effects and Toxicity Studies (50 papers) and Neuroscience and Neuropharmacology Research (27 papers). Antonio Laurenza collaborates with scholars based in United States, United Kingdom and Japan. Antonio Laurenza's co-authors include Haichen Yang, Kenneth B. Seamon, Elizabeth McHugh Sutkowski, Gregory L. Krauss, David Squillacote, Jacqueline A. French, Betsy Williams, Mahnaz Asgharnejad, Bernhard J. Steinhoff and Anna Patten and has published in prestigious journals such as Neurology, Biochemistry and PEDIATRICS.

In The Last Decade

Antonio Laurenza

87 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Laurenza United States 29 2.3k 1.7k 1.5k 600 413 93 3.3k
Eylert Brodtkorb Norway 35 1.9k 0.8× 1.5k 0.9× 740 0.5× 614 1.0× 137 0.3× 132 3.5k
Erik Taubøll Norway 34 2.1k 0.9× 1.8k 1.0× 779 0.5× 708 1.2× 316 0.8× 145 3.6k
Marco Sifringer Germany 37 696 0.3× 1.6k 1.0× 1.0k 0.7× 1.4k 2.3× 258 0.6× 73 4.6k
Victor Biton United States 32 3.3k 1.4× 2.9k 1.7× 1.5k 1.0× 282 0.5× 402 1.0× 78 4.1k
Tapani Keränen Finland 31 1.3k 0.6× 820 0.5× 705 0.5× 329 0.5× 189 0.5× 93 2.6k
J. Bruni Canada 29 914 0.4× 1.3k 0.7× 963 0.7× 422 0.7× 147 0.4× 93 2.6k
Allan L. Sherwin Canada 30 1.2k 0.5× 851 0.5× 1.3k 0.9× 877 1.5× 246 0.6× 92 3.1k
D. Schmidt Germany 26 1.7k 0.7× 1.3k 0.8× 788 0.5× 276 0.5× 87 0.2× 75 2.4k
Elizabeth A. Garofalo United States 18 1.0k 0.4× 761 0.4× 586 0.4× 214 0.4× 509 1.2× 20 1.9k
M.J. Leach United Kingdom 20 628 0.3× 436 0.3× 1.1k 0.7× 651 1.1× 227 0.5× 49 2.3k

Countries citing papers authored by Antonio Laurenza

Since Specialization
Citations

This map shows the geographic impact of Antonio Laurenza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Laurenza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Laurenza more than expected).

Fields of papers citing papers by Antonio Laurenza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Laurenza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Laurenza. The network helps show where Antonio Laurenza may publish in the future.

Co-authorship network of co-authors of Antonio Laurenza

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Laurenza. A scholar is included among the top collaborators of Antonio Laurenza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Laurenza. Antonio Laurenza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ionescu, Adrian, Maura Furey, Manish K. Jha, et al.. (2025). A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 45(5). 432–440.
2.
Shanbhag, Niraj M., Jaya Padmanabhan, Zheng Zhang, et al.. (2025). An Acetylcholine M1 Receptor–Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment. JAMA Neurology. 82(2). 152–152. 5 indexed citations
3.
Simen, Arthur A., et al.. (2025). M1 receptor positive allosteric modulators discovery approaches. Trends in Pharmacological Sciences. 46(4). 298–302.
4.
Rektor, Ivan, Gregory L. Krauss, Yushi Inoue, et al.. (2020). Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies. Epilepsia. 61(7). 1491–1502. 15 indexed citations
5.
Piña-Garza, J. Eric, Lieven Lagae, Vicente Villanueva, et al.. (2018). Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures. Epilepsy & Behavior. 83. 50–58. 36 indexed citations
6.
Gidal, Barry E., Rama Maganti, Antonio Laurenza, et al.. (2017). Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters. Epilepsy Research. 134. 41–48. 23 indexed citations
7.
8.
O'Brien, TJ, et al.. (2016). MYOCLONIC AND ABSENCE SEIZURES IN PATIENTS WITH IDIOPATHIC GENERALIZED EPILEPSY (IGE): EXPLORATORY OUTCOMES IN A PHASE III PGTC STUDY WITH ADJUNCTIVE PERAMPANEL. Epilepsia. 57. 1 indexed citations
9.
10.
Ettinger, Alan B., Haichen Yang, Betsy Williams, et al.. (2015). Review of Suicidality Events in Perampanel Clinical Studies (S31.001). Neurology. 84(14_supplement). 2 indexed citations
11.
Laurenza, Antonio, Haichen Yang, Betsy Williams, Sharon Zhou, & Jim Ferry. (2015). Absence of Liver Toxicity in Perampanel-Treated Subjects: Pooled results from partial seizure phase III perampanel clinical studies. Epilepsy Research. 113. 76–85. 9 indexed citations
12.
Laurenza, Antonio, et al.. (2015). Subgroup Analysis By Race in Perampanel Phase III Clinical Studies (P1.254). Neurology. 84(14_supplement). 1 indexed citations
13.
Rogawski, Michael A., Haichen Yang, Reginald V. Fant, et al.. (2015). Perampanel Discontinuation Is Not Associated With Self-Reported Withdrawal Symptoms in Patients Completing Phase III Clinical Studies (P1.232). Neurology. 84(14_supplement). 1 indexed citations
14.
Hussein, Ziad, Barry E. Gidal, Haichen Yang, et al.. (2015). Pharmacokinetic, Pharmacodynamic and Cognitive Effects of Adjunctive Perampanel in Adolescents With Inadequately Controlled Partial Seizures (P1.255). Neurology. 84(14_supplement). 1 indexed citations
15.
Renfroe, J. Ben, Lieven Lagae, Betsy Williams, et al.. (2015). Adjunctive Perampanel in Adolescents With Inadequately Controlled Partial Seizures: Efficacy and Safety Results From Study 235 (Phase II) (P7.008). Neurology. 84(14_supplement). 2 indexed citations
16.
Glauser, Tracy A., Antonio Laurenza, Haichen Yang, et al.. (2014). Efficacy and Safety of Adjunctive Perampanel Based on Number of Antiepileptic Drugs at Baseline (P3.273). Neurology. 82(10_supplement). 1 indexed citations
17.
Gidal, Barry E., Oneeb Majid, Jim Ferry, et al.. (2014). The practical impact of altered dosing on perampanel plasma concentrations: Pharmacokinetic modeling from clinical studies. Epilepsy & Behavior. 35. 6–12. 25 indexed citations
18.
Leppik, Ilo E., Haichen Yang, Betsy Williams, et al.. (2014). Analysis of Falls in Epilepsy Patients with Partial Onset Seizures in Perampanel Phase 3 Trials (P3.272). Neurology. 82(10_supplement). 1 indexed citations
19.
Laurenza, Antonio & Kenneth B. Seamon. (1991). [5] High-affinity binding sites for [3H]forskolin. Methods in enzymology on CD-ROM/Methods in enzymology. 195. 52–65. 20 indexed citations
20.
Laurenza, Antonio, et al.. (1990). Irreversible loss of [3H]forskolin binding sites in human platelets by alpha-haloacetyl analogs of forskolin.. Molecular Pharmacology. 37(1). 69–74. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eylert Brodtkorb Breakdown of academic impact, for papers by Erik Taubøll Breakdown of academic impact, for papers by Marco Sifringer Breakdown of academic impact, for papers by Victor Biton Breakdown of academic impact, for papers by Tapani Keränen Breakdown of academic impact, for papers by J. Bruni Breakdown of academic impact, for papers by Allan L. Sherwin Breakdown of academic impact, for papers by D. Schmidt Breakdown of academic impact, for papers by Elizabeth A. Garofalo Breakdown of academic impact, for papers by M.J. Leach
Rankless by CCL
2026